OEC 241220 17.50C (OEC241220C17500) Stock Options, News & Quotes

0.70
0.000.00%

15min DelayClose Nov 21 16:00 ET

0.00High0.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Stock_Drift

Oct 20 17:16

$AERIUS (AERS.US)$ $Alphabet-C (GOOG.US)$ $Orion SA (OEC.US)$

Moomoo AI

Mar 22 06:11

Orion is undervalued compared to peers, with high volatility presenting buying opportunities. Optimistic future earnings could boost cash flows and share value, but financial health is also crucial.

Is Orion S.A. (NYSE:OEC) Potentially Undervalued?

Moomoo Breakfast US

Jun 17, 2022 07:29

Columns Today's pre-market stock movers: X, REV, ROKU, BHC and more

Gainers:
• $Revlon (REV.US)$ +81% (Reliance mulling buyout of REV according to Economic Times)
• $United States Steel (X.US)$ +6.4% (issues upside EPS guidance),
• $Ellington Financial (EFC.US)$ +5% (reports book value per share)
• $Aurora Mobile (JG.US)$ +4.9% (receives RMB15 mln in special support funding from the Shenzhen Development and Reform Commission)
• $Citi Trends (CTRN.US)$ +4.4% (names new CFO)
• $Roku Inc (ROKU.US)$ +4.2% (ROKU an...

Moomoo Breakfast US

Mar 31, 2022 07:53

Columns Today's pre-market stock movers: CLVS, PATH, DARE and more

Gainers:
• $Clovis Oncology (CLVS.US)$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $Dare Bioscience (DARE.US)$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR Technology (KULR.US)$ +9.5% (secured a battery sa...